Profile

	Prof. Dipankar De
	Designation : Professor
	Department : DERMATOLOGY VENEREOLOGY LEPROLOGY
	de.dipankar@pgimer.edu.in

:: Contact Details

Phone No.

9914208802

Ext No.

:: Educational Qualification

Graduation

MBBS from Calcutta Medical College Kolkata in year 2000

Post Graduation

MD Dermatology from PGIMER Chandigarh in year 2005

:: Area of Interest

Area Of Interest

Acne

Iimmunobullous Diseases

Contact Dermatitis

Photobiology and Phototherapy

Dermatopathology

Lichen Planus

Autoimmune bullous diseases

Oral diseases

Pediatric Dermatology

Eczemas

Hidradenitis Suppurativa

Cutaneous lymphomas

:: Research & Projects

Research In
Progress

Guide to research work

Year	Title of research work	Name of the student	Guide/ Co-guide
2013- Completed	Role of insulin like growth factor-1(IGF-1) gene polymophism and serum IGF-1 levels in acne severity	Dr Amanur Rahaman	Guide of MD thesis
2013- Completed	Prevalence of metabolic syndrome and insulin resistance in male patients with acne	Dr Mohit Nagpal	Guide of MD thesis
2014- Completed	Assessment of correlation between T Regulatory cell count in peripheral blood with clinical severity of pemphigus vulgaris and alteration of these variables after rituximab treatment	Dr Rajsmita Bhattachrjee	Guide of MD thesis
2014- completed	Comparative efficacy and safety of oral methotrexate and topical triamcinolone acetonide in erosive oral lichen planus	Dr Payal Chauhan	Guide of MD thesis
2015- Completed	Identification of factors predicting treatment refractoriness of oral lesions of pemphigus vulgaris	Dr Sheetanshu Kumar	Guide of MD thesis
2016- Completed	Identification of clinical and immunological factors in prediction of clinical relapse in pemphigus	Dr Ankur Guliani	Guide of MD thesis
2016- Completed (PhD thesis)	Assessment of the role of metformin in regulation of IGF-1 mediated pathway in the pathogenesis of acne	Ms Parul Kamboj	Guide
2017- Completed	Development and validation of novel scoring system for oral lesions in pemphigus vulgaris	Dr Sindhuja T	Guide of MD thesis
2018- Completed	A randomised trial of prednisolone and methotrexate Vs prednisolone alone to assess the adjuvant potential of methotrexate in mucosal/ limited mucocutaneous pemphigus vulgaris	Dr Khimit Jain	Guide of MD thesis
2018- Completed	To assess the role of FcgRIIIA expression in peripheral blood mononuclear cells on treatment response with rituximab in patients of pemphigus - An observational study	Dr Ankur Sharma	Guide of MD thesis
2018- Completed	Comparative study to assess the efficacy and cost efficiency of immunologically- guided novel rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigus	Dr Namrata Singh	Co-guide of MD thesis
2020- Completed	A comparison of c3d and c4d immunohistochemical staining in formalin fixed skin biopsy specimen against combined clinical and direct immunofluorescence diagnosis as benchmark in bullous pemphigoid and mucous membrane pemphigoid	Dr Neha Thakur	Guide of MD Thesis
2021- Completed	Determination of usability of validated scoring Criteria for assessment of disease severity of pemphigus by telecommunication	Dr Prarthana T	Guide of MD Thesis
2021- Completed	Utility of plucked hair direct immunofluorescence as a possible replacement of conventional skin biopsy direct immunofluorescence in immunological activity monitoring and prediction of relapse in pemphigus	Dr Kittu Malhi	Guide of MD Thesis
2022- Completed	Assessment of clinical, biochemical, and hormonal characteristics and selected genetic polymorphisms in male siblings of women with confirmed polycystic ovarian syndrome	Dr Sukhmanjeet Singh	Guide of MD Thesis
2022- Ongoing	Determination of role of BP-180 gene in possible variation of target site and autoantibody specificity in Bullous pemphigoid and Mucous membrane pemphigoid resulting in mucosal scarring in Mucous membrane pemphigoid	Ms Sakshi Agarwal	Guide of PhD thesis
2023- Ongoing	Assessment of efficacy of combination of low dose rituximab and low dose prednisolone vs low dose prednisolone in inducing repeat remission in rituximab treated pemphigus vulgaris patients who develop disease relapse : A randomised controlled trial	Dr Ishita	Guide of MD Thesis
2024- Ongoing	A cross-sectional study to evaluate clinical determinants of atopic march in Indian children aged 11-18 years with atopic dermatitis and/ or with asthma	Dr Tilak Raj	Guide of MD Thesis

Other research projects

Subject of Research	Position	Funding agency
Melasma in men a clinical and etiological study	Co-investigator	IADVL- Loreal research grant (completed)
In search of new sebostatic agents: assessment of role of H1 antihistamines and cannabidiols in sebaceous gland function	Investigator	IADVL- Loreal, Completed
Assessment of role of FoxO1 in acne and effects of Isotretinoin on FoxO1 expression- a pilot study	Investigator	PGIMER intramural research grant
Role of Insulin Like Growth Factor-1 Receptor (IGF-1R) polymorphism and IGF-1 receptor expression in acne and its severity	Investigator	PGIMER- intramural- Completed
1. Clinical and pathological characterization of lichenoid lesions in oral pemphigus vulgaris	Investigator	IADVL Research Grant 2015- completed
Assessment of efficacy of topical pilocarpine 2% eye-drops in treatment of refractory/ persistent oral lesions of pemphigus vulgaris- a pilot study	Co-investigator	IADVL research grant 2017- completed
Immunological factors predicting clinical relapse in pemphigus	Investigator	European Academy of Dermatology and Venereology-2017- Completed
Delving into the pathogenic role of pesticides in pemphigus- to compare anti-desmoglein antibodies titres and anti- M3 muscarinic acetylcholine receptor antibody titres as surrogate markers for pemphigus between subjects who are occupationally exposed and not exposed to pesticides	Investigator	IADVL Research Grant 2018- Completed
Role of therapeutic modulation of circulating levels of insulin/ insulin like growth factor-1 (IGF-1) on acne in young adults- an observational study	Investigator	PGIMER- intramural- completed
Systems medicine approach to tackle the problems of early diagnosing and prognostic stratification of mycosis fungoides	Investigator	Department of Biotechnology (India)- Swiss National Science Foundation (Switzerland)
Validation of a simplified severity score (Investigator Global Assessment: IGA) in bullous pemphigoid	Co- investigator	University of Rouen, France
A Randomized, Double-Blinded, Double-Dummy, Active-Comparator Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC Compared to Rituximab in Adult Patients with Moderate or Severe Pemphigus (Vulgaris or Foliaceus)	Investigator (Global regulatory clinical trial)	Argenx BVBA- Completed
An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Pemphigus	Investigator (Global regulatory clinical trial)	Argenx BVBA- Completed
Exploration of role of BP180 and LAM332 genetic variants and altered protein function in frequent ocular involvement and fibrosis in mucous membrane pemphigoid and not in bullous pemphigoid	Investigator	Science and Engineering Research Board (Department of Science and Technology)

Awards & Honours

· Indubala Memorial Award, 2013, 2015 (Indian Association of Dermatologists Venereologists and Leprologists) for best original article on Occupational Dermatoses published in IJDVL.

· L.N. Sinha Memorial Award-2016 by Indian Association of Dermatologists, Venereologists and Leprologists.

· Awarded Membership of the National Academy of Medical Sciences (India)- 2017

· Prof. L.K. Bhutani Award-2018 by Indian Association of Dermatologists, Venereologists and Leprologists.

· Prof J.N. Shetty Memorial Oration- 2023 by Prof J.N. Shetty Memorial Oration Trust, Father Muller Medical College, Mangalore

· Dr B.C. Lahiri Memorial Oration- 2024 by West Bengal State Branch of Indian Association of Dermatologists, Venereologists and Leprologists

· Award of appreciation in the Institute Research Day (PGIMER, Chandigarh) for best published article (Additional Professors)- 2017, 2018

· Award to the guide for best paper presented in the thesis- based award paper session in the national conference of the Indian Association of Dermatologists, Venereologists and Leprologists (DERMACON 2020) for the thesis entitled Development and validation of a novel scoring system for oral lesions in pemphigus vulgaris.

· Dr B.V. Satyanarayana Memorial Award 2017 for best thesis was awarded to Dr Sheetanshu Kumar by Indian Association of Dermatologists, Venereologists and Leprologists for his thesis entitled Identification of factors predicting treatment refractoriness of oral lesions of pemphigus vulgaris guided by Dr Dipankar De.

· Dr B.V. Satyanarayana Memorial Award 2019 for best thesis was awarded to Dr Sindhuja T by Indian Association of Dermatologists, Venereologists and Leprologists for her thesis entitled Development and validation of a novel scoring system for oral lesions in pemphigus vulgaris guided by Dr Dipankar De.

· Dr B.V. Satyanarayana Memorial Award 2023 for best thesis was awarded to Dr Kittu Malhi by Indian Association of Dermatologists, Venereologists and Leprologists for her thesis entitled Utility of plucked hair direct immunofluorescence as a possible replacement of conventional skin biopsy direct immunofluorescence in immunological activity monitoring and prediction of relapse in pemphigus guided by the applicant.

Member Of Professional
Bodies

Indian Association of Dermatologists Venereologists and Leprologists

Contact and Occupational Dermatoses Forum of India

Dermatopathology Society of India

International Fellow American Academy of Dermatology

International Society of Dermatology

International Society of Dermatopathology

European Academy of Dermatology and Venereology

Association of Cutaneous Surgeons of India

National Academy of Medical Sciences

Society for Eczema Studies

:: Publications(In Vancouver Style)

1. De D, Kanwar AJ, Handa S. Comparative efficacy of Hanifinand Rajkas criteria and U.K. working partys diagnostic criteria in diagnosisatopic dermatitis in a hospital setting in North India. J Eur Acad DermatolVenereol 2006; 20: 853- 59.

2. Bhatnagar A, KanwarAJ, Parsad D, De D. Comparison of systemic PUVA and NBUVB in treatmentof vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 638- 42.

3. Bhatnagar A,Kanwar AJ, Parsad D, De D. Psoralen ultraviolet A and narrowband ultraviolet B in inducing stability in vitiligo, assessed by vitiligodisease activity score- an open prospective comparative study. J Eur AcadDermatol Venereol 2007;21:1381-85.

4. Kaur I, Dogra S, De D, Kanwar AJ. Systemic methotrexate treatment in childhoodpsoriasis: further experience in 24 children from India. Pediatr Dermatol 2008;25:184-88.

5. De D, Narang T, Dogra S,Kanwar AJ. Asymptomatic palmar pits:Clinical evaluation of six cases and review of the literature. J Cutan Med Surg2008;12:198-202.

6. Kaur I, Dogra S, De D, Saikia UN. Histoid leprosy:a retrospective study of 40 cases from India. Br J Dermatol 2009;160:305-310.

7. Kumar U, Kaur I,Dogra S, De D, Kumar B.Topical tazarotene versus coal tar in chronic plaque type psoriasis. Clin ExpDermatol 2010;35:482-6.

8. Kanwar AJ, DeD. Lichen planus in childhood:Report of 100 cases. Clin Exp Dermatol 2010;35:257-62.

9. Kaur I, Dogra S,Narang T, De D. Comparativeefficacy of thalidomide and prednisolone in the treatment of moderate to severeerythema nodosum leprosum- A randomized study. Australas J Dermatol 2009;50:181-5.

10. Chauhan PS, Kaur I, Dogra S, De D, Kanwar AJ. Narrow- band UVB Vs Psoralen plus UVA therapy intreatment of severe plaque psoriasis- an Indian perspective. Clin Exp Dermatol.2011;36:169-73.

11. Kanwar AJ, DeD. Lichen planus in children.Indian J Dermatol Venereol Leprol 2010;76:366-72.

12. Dogra S, De D. Phototherapy and photochemotherapy inchildhood dermatoses. Indian J Dermatol Venereol Leprol 2010;76:521-26.

13. Dogra S, De D. Narrow band UVB in psoriasis- thejourney so far. Indian J Dermatol Venereol Leprol 2010;76:652-61.

14. De D, Kanwar AJ. Combinationof low- dose isotretinoin and pulsed oral azithromycin in management ofmoderate to severe acne- a preliminary open prospective non- comparative study.Clin Drug Invest 2011;31:599-604.

15. Kanwar AJ, DeD. Pemphigus in India. Indian J Dermatol Venereol Leprol 2011;77:439-49.

16. Kanwar AJ, DeD. Epidemiology and clinical features of atopic dermatitis in India. IndianJ Dermatol 2011;56:471-5.

17. De D, Handa S. Filaggrin mutations and the skin. Indian JDermatol Venereol Leprol. 2012;78:545-51.

18. Kanwar AJ, DeD. Methotrexate for treatment of lichen panus: old drug, new indication. JEur Acad Dermatol Venereol. 2013;27:e410-13.

19. Kumaran MS, DeD. Basic genetics for dermatologists. Indian J Dermatol Venereol Leprol2013;79:457-68.

20. Tripathi JP,Patro BK, De D, Singh AJ,Kanwar AJ. Diagnostic agreement between a primary carephysician and a tele-dermatologist for common dermatological conditions inNorth India. Indian Dermatology Online Journal. 2015;6:21-6.

21. De D, Khullar G, Handa S. Performance of a commerciallyavailable plant allergen series in the assessment of suspected occupationalcontact dermatitis to plants in north Indian patients. Indian J DermatolVenereol Leprol 2015:81:376-79.

22. Sharma R, HandaS, De D, Radotra BD, RattanV. Role of dental restoration materialsin oral mucosal lichenoid lesions- an Indian perspective. Indian JDermatol Venereol Leprol. 2015;81:478-84.

23. De D, Khullar G, Handa S, Saikia UN, Radotra BD, Saikia B,Minz RW. Clinical, demographic and immunopathological spectrum of subepidermalautoimmune bullous diseases at a tertiary center: A 1-year audit. Indian JDermatol Venereol Leprol. 2016;82:358.

24. Nagpal M, De D,Handa S, Pal A, Sachdeva N. Insulin resistance and metabolic syndrome in acne.JAMA Dermatol.2016;152:399-404.

25. Sachdeva RK,Sharma A, De D, Malhi J, Rewari BB, Singh S, Varma S. Lamivudine-InducedSkin Rash Remains an Underdiagnosed Entity in HIV: A Case Series from a SingleCenter. J Int Assoc Provid AIDS Care. 2016;15:153-8.

26. Khullar G, SaikiaUN, De D, Handa S, Radotra BD. Predisposing factors andhistopathological variants of cutaneous squamous cell carcinoma: Experiencefrom North Indian teaching hospital. Indian J Dermatol Venereol Leprol.2016;82:273-8.

27. Rahaman SMA, DeD, Handa S, Sachdeva N, Ghosh T, Kamboj P. Association of insulin-likegrowth factor-1 (IGF-1) gene polymorphisms with plasma levels of IGF-1 and acneseverity. J Am Acad Dermatol 2016;75:768-73.

28. Bhattacharjee R, DeD, Handa S, Minz RW, Saikia B,Joshi N. Assessment of the effects of rituximab monotherapy on differentsubsets of circulating T-regulatory cells and clinical disease severity insevere pemphigus vulgaris. Dermatology 2016;232:572-77.

29. Kumar S, De D, Handa S, Ratho RK, Bhandari S, Pal A,Kamboj P, Sarkar S. Identification of factors associated with treatmentrefractoriness of oral lesions in pemphigus vulgaris. Br J Dermatol2017;177:1583-89.

30. De D, Khullar G, Handa S, Joshi N, SaikiaB, Minz RW. Correlation between salivary and serum anti-desmoglein 1 and 3antibody titers using ELISA and between anti-desmoglein levels and diseaseseverity in pemphigus vulgaris. Clin Exp Dermatol. 201742:648-650.

31. Handa S, De D,Khullar G, Radotra BD, Sachdeva N. The clinicoaetiological, hormonal andhistopathological characteristics of melasma in men. Clin Exp Dermatol.2018;43:36-41.

32. Chauhan P, DeD, Handa S, Narang T, Saikia UN. A prospective observational study tocompare efficacy of topical triamcinolone acetonide 0.1% oral paste, oralmethotrexate, and a combination of topical triamcinolone acetonide 0.1% andoral methotrexate in moderate to severe oral lichen planus. Dermatol Ther. 2018Jan;31(1). doi: 10.1111/dth.12563.

33. Bhusari P, ShuklaJ, Kumar M, Vatsa R, Chhabra A, Palarwar K, Rathore Y, De D, Kumaran S,Handa S, Mittal BR. Noninvasive treatment of keloid using customized Re-188skin patch. Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12515.

34. Lath K,Chatterjee D, Saikia UN, Saikia B, Minz R, De D, Handa S, Radotra B.Role of Direct Immunofluorescence in Cutaneous Small-Vessel Vasculitis:Experience From a Tertiary Center. Am J Dermatopathol. 2018 Sep;40(9):661-666.

35. Handa S, Dabas G,De D, Mahajan R, Chatterjee D, Saika UN, Radotra BD. A retrospectivestudy of dermatitis herpetiformis from an immunobullous disease clinic in northIndia. Int J Dermatol. 2018 Aug;57(8):959-964.

36. Chougule A,Chatterjee D, Yadav R, Sethi S, De D, Saikia UN. Granulomatous RosaceaVersus Lupus Miliaris Disseminatus Faciei-2 Faces of Facial GranulomatousDisorder: A Clinicohistological and Molecular Study. Am J Dermatopathol.2018Nov;40(11):819-823.

37. Chatterjee D,Vishwajeet V, Saikia UN, Radotra B, De D, Bansal D. CyclinD1 Is Usefulto Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells.Am J Dermatopathol. 2019 Mar;41(3):188-192.

38. Handa S, KhullarG, Pal A, Kamboj P, De D. Filaggrin gene mutations in hand eczemapatients in the Indian subcontinent: A prospective case-control study. ContactDermatitis. 2019 Jun;80(6):359-364.

39. Kaushik A, DeD, Handa S, Mittal A. To determine irradiance of ultraviolet A in ambientsunlight and optimum exposure time for PUVAsol in a North Indian location.Indian J Dermatol Venereol Leprol. 2019 Sep-Oct;85(5):462-465.

40. De D, Bishnoi A,Handa S, Mahapatra T, Mahajan R. Effectiveness and safety analysis of rituximabin 146 Indian pem phigus patients: A retrospective single-center review of upto 68 months follow-up. Indian J Dermatol Venereol Leprol. 2020;86:39-44.

41. De D, Singh S.Basic Understanding of study types and formulating research question for aclinical trial. Indian Dermatol Online J. 2019 May-Jun;10(3):351-353. doi:10.4103/idoj.IDOJ_56_19.

42. JolyP, Horvath B, Patsatsi Α, Uzun S, Bech R, Beissert S, Bergman R, Bernard P,Borradori L, Caproni M, Caux F, Cianchini G, Daneshpazhooh M, De D,Dmochowski M, Drenovska K, Ehrchen J, Feliciani C, Goebeler M, Groves R,Guenther C, Hofmann S, Ioannides D, Kowalewski C, Ludwig R, Lim YL, MarinovicB, Marzano AV, Mascaró JM Jr, Mimouni D, Murrell DF, Pincelli C, Squarcioni CP,Sárdy M, Setterfield J, Sprecher E, Vassileva S, Wozniak K, Yayli S, ZambrunoG, Zillikens D, Hertl M, Schmidt E. Updated S2K guidelines on the management ofpemphigus vulgaris and foliaceus initiated by the european academy ofdermatology and venereology (EADV). J Eur Acad Dermatol Venereol. 2020Sep;34(9):1900-1913. doi: 10.1111/jdv.16752. Epub 2020 Aug 24. PMID: 32830877.

43. KaushikA, Mahajan R, De D, Handa S. Paediatric morphoea: a holistic review.Part 1: epidemiology, aetiopathogenesis and clinical classification. Clin ExpDermatol. 2020 Aug;45(6):673-678. doi: 10.1111/ced.14234. Epub 2020 May 30.PMID: 32472964.

44. KaushikA, Mahajan R, De D, Handa S. Paediatric morphoea: a holistic review.Part 2: diagnosis, measures of disease activity, management and naturalhistory. Clin Exp Dermatol. 2020 Aug;45(6):679-684. doi: 10.1111/ced.14236.Epub 2020 May 24. PMID: 32449205.

45. ChatterjeeD, Bhattacharjee R, Khullar G, Kumaran S, De D, Saikia UN, Radotra BD.Metastatic Crohn Disease: A Clinicohistological Appraisal From a Tertiary CareCenter in India. Am J Dermatopathol. 2020 Jul;42(7):506-512. doi:10.1097/DAD.0000000000001543. PMID: 31693502.

46. MahajanR, Daroach M, De D, Handa S. Clinico-Dermoscopic Features and TreatmentResponsiveness in Pediatric Alopecia - Experience from a Tertiary CarePediatric Dermatology Clinic. Indian J Dermatol. 2020 Nov-Dec;65(6):483-488.doi: 10.4103/ijd.IJD_121_19. PMID: 33487703; PMCID: PMC7810076.

47. GulianiA, De D, Handa S, Mahajan R, Sachdeva N, Radotra BD, Kishore K.Identification of clinical and immunological factors associated with clinicalrelapse of pemphigus vulgaris in remission. Indian J Dermatol Venereol Leprol.2020 May-Jun;86(3):233-239. doi: 10.4103/ijdvl.IJDVL_89_19. PMID: 31898637.

48. GuptaN, Bishnoi A, Mathew D, Arora A, Handa S, Kaur J, De D, Pal A.Hypertrophic post-acne scarring is associated with a single nucleotidepolymorphism (rs243865) in the matrix metalloproteinase-2 gene. J DtschDermatol Ges. 2020 Dec;18(12):1426-1435. doi: 10.1111/ddg.14338. PMID:33373134.

49. De D, Arora AK, Handa S, Chatterjee D,Saikia UN, Radotra BD, Kishore K, Khullar G. Clinical and pathologicalcharacterization of oral mucosal 'lichen planus-like lesions' in patients withpemphigus vulgaris: An observational study. Indian J Dermatol Venereol Leprol.2020 May-Jun;86(3):278-283. doi: 10.4103/ijdvl.IJDVL_129_18. PMID: 31031312.

50. SindhujaT, De D, Handa S, Goel S, Mahajan R, Kishore K. Pemphigus Oral LesionsIntensity Score (POLIS): A Novel Scoring System for Assessment of Severity ofOral Lesions in Pemphigus Vulgaris. Front Med (Lausanne). 2020 Sep 2;7:449.doi: 10.3389/fmed.2020.00449. PMID: 32984362; PMCID: PMC7492520.

51. BhatS, Handa S, De D. A randomized comparative study of the efficacy oftopical latanoprost versus topical betamethasone diproprionate lotion in thetreatment of localized alopecia areata. Indian J Dermatol Venereol Leprol. 2021Jan-Feb;87(1):42-48. doi: 10.25259/IJDVL_787_19. PMID: 33580923.

52. ParkhiM, Kumar S M, De D, Yadav R, Sethi S, Radotra BD, Saikia UN. DiagnosticUtility of Biplex/Multiplex Polymerase Chain Reaction in InfectiousGranulomatous Dermatitis in North Indian Population. Am J Dermatopathol. 2020Dec 29;Publish Ahead of Print. doi: 10.1097/DAD.0000000000001878. Epub ahead ofprint. PMID: 33395043.

53. BishnoiA, De D, Handa S, Mahajan R. Biologics in autoimmune bullous diseases:Current scenario. Indian J Dermatol Venereol Leprol. 2021Sep-Oct;87(5):611-620. doi: 10.25259/IJDVL_886_19.

54. KambojP, Bishnoi A, Handa S, Dutta P, Nahar Saikia U, Pal A, De D. Effects ofmetformin on experimentally induced acne on rabbit ear. Exp Dermatol. 2021Jul;30(7):966-972. doi: 10.1111/exd.14347.

55. ShanmughamHA, Handa S, De D, Dhillon MS, Aggarwal S. An observational study todetermine the sensitizing potential of orthopedic implants. Indian J DermatolVenereol Leprol. 2021 Nov-Dec;87(6):826-830. doi: 10.4103/ijdvl.IJDVL_789_18.

56. BakshiS, Mahajan R, Karim A, De D, Handa S, Saikia B. Oral vitamin Dversus acitretin in congenital non-syndromic ichthyosis: double blinded,randomized controlled trial. J Dtsch Dermatol Ges. 2022 Mar;20(3):297-304. doi:10.1111/ddg.14666.

57. Handa S, Mehta H,Bishnoi A, Vinay K, Mahajan R, Narang T, Kumaran MS, De D, Dogra S,Parsad D. Teledermatology during the COVID-19 pandemic: Experience at atertiary care centre in North India. Dermatol Ther. 2021 Jul;34(4):e15022. doi:10.1111/dth.15022. Epub 2021 Jun 14.

58. Gupta P, Joshi N,Uprety S, Dogra S, De D, Handa S, Minz RW, Singh S, Chhabra S. Associationof MIF gene polymorphisms with pemphigus vulgaris: acase-control study with comprehensive review of the literature. Int J Clin ExpPathol. 2021 Nov 15;14(11):1080-1089.

59. Görög A, AntigaE, Caproni M, Cianchini G, De D, Dmochowski M, Dolinsek J, Drenovska K,Feliciani C, Hervonen K, Lakos Jukic I, Kinyó Á, Koltai T, Korponay-Szabó I,Marzano AV, Patsatsi A, Rose C, Salmi T, Schmidt E, Setterfield J, Shahid M,Sitaru C, Uzun S, Valitutti F, Vassileva S, Yayli S, Sárdy M. S2k guidelines(consensus statement) for diagnosis and therapy of dermatitis herpetiformisinitiated by the European Academy of Dermatology and Venereology (EADV). J EurAcad Dermatol Venereol. 2021 Jun;35(6):1251-1277. doi: 10.1111/jdv.17183.

60. NingombamA, Handa S, Srivastava N, Mahajan R, De D. Addition of oral fexofenadineto topical therapy leads to a significantly greater reduction in the seruminterleukin-31 levels in mild to moderate paediatric atopic dermatitis. ClinExp Dermatol. 2022 Apr;47(4):724-729. doi: 10.1111/ced.15032. Epub 2022 Jan 6.PMID: 34826148.

61. De D, Kumar S, Handa S, Mahajan R, Singh SM. Psychologicalmorbidity in pemphigus patients in clinical remission and its relation withclinico-demographic parameters. J Dtsch Dermatol Ges. 2022 Jan;20(1):26-33. doi:10.1111/ddg.14605. Epub 2021 Nov 25. PMID: 34821016.

62. MahajanR, Manjunath S, Madakshira MG, Chatterjee D, Bishnoi A, De D, Handa S,Dass Radotra B, Jamwal M, Das R. Correlating clinical and laboratory diagnosticmodalities in the diagnosis of epidermolysis bullosa in a resource-poorsetting. J Cutan Pathol. 2022 May;49(5):454-459. doi: 10.1111/cup.14208. Epub2022 Feb 15. PMID: 35119710.

63. De D, Bishnoi A, Shilpa, Kamboj P, Arora AK, Pal A,Mahajan R, Handa S. Effectiveness of topical pilocarpine in refractory orallesions of pemphigus vulgaris: Results from an open-label, prospective, pilotstudy. Dermatol Ther. 2022 Mar 14:e15449. doi: 10.1111/dth.15449.

64. Bishnoi A,Manjunath S, Kishore K, De D, Handa S, Murrell DF, Mahajan R. Hinditranslation and validation of quality of life score in Indian patients withepidermolysis bullosa; and its correlation with the clinical severityassessment scores: A cross-sectional study. Indian J Dermatol Venereol Leprol.2022 Mar-Apr;88(2):177-183. doi: 10.25259/IJDVL_31_20.

65. BorradoriL, Van Beek N, Feliciani C, Tedbirt B, Antiga E, Bergman R, Böckle BC, CaproniM, Caux F, Chandran NS, Cianchini G, Daneshpazhooh M, De D, Didona D, DiZenzo GM, Dmochowski M, Drenovska K, Ehrchen J, Goebeler M, Groves R, GüntherC, Horvath B, Hertl M, Hofmann S, Ioannides D, Itzlinger-Monshi B, JedličkováJ, Kowalewski C, Kridin K, Lim YL, Marinovic B, Marzano AV, Mascaro JM, MeijerJM, Murrell D, Patsatsi K, Pincelli C, Prost C, Rappersberger K, Sárdy M,Setterfield J, Shahid M, Sprecher E, Tasanen K, Uzun S, Vassileva S,Vestergaard K, Vorobyev A, Vujic I, Wang G, Wozniak K, Yayli S, Zambruno G,Zillikens D, Schmidt E, Joly P. Updated S2 K guidelines for the management ofbullous pemphigoid initiated by the European Academy of Dermatology and Venereology(EADV). J Eur Acad Dermatol Venereol. 2022 Oct;36(10):1689-1704. doi:10.1111/jdv.18220. Epub 2022 Jun 29. PMID: 35766904.

66. KaushikH, Mahajan R, Dabas G, Shrivastava N, Ashraf R, De D, Pal A, Kumar R,Handa S. A cross-sectional study to find association of VDR gene polymorphismwith non-syndromic congenital ichthyosis and with vitamin D deficiency. ArchDermatol Res. 2022 Oct 3. doi: 10.1007/s00403-022-02399-z. Epub ahead of print.PMID: 36192561.

67. SainiL, Mukherjee S, Gunasekaran PK, Malhi P, Saini AG, De D, Padhy S, AhujaC, Suthar R, Sahu JK, Sankhyan N, Yadav J, Sharawat IK. Sleep Problems inChildren With Neurocutaneous Syndromes: A Cross-Sectional Study. J ChildNeurol. 2022 Oct;37(10-11):864-870. doi: 10.1177/08830738221114560. Epub 2022 Aug2. PMID: 35918819.

68. ChhabraA, Pandey S, Rathore Y, Kaur G, Lakhanpal T, Singh Tanwar K, Kumaran MS, DeD, Shukla J. Nuclear medicine in the management of superficial skinabnormalities and institutional experience. Nucl Med Commun. 2022 Jun1;43(6):625-630. doi: 10.1097/MNM.0000000000001549. Epub 2022 Apr 1. PMID:35362693.

69. AfraTP, Daroach M, Mahajan R, De D, Handa S. Pustular lesions in theneonate: Focused diagnostic approach based on clinical clues. Indian J DermatolVenereol Leprol. 2022 Aug 27:1-9. doi: 10.25259/IJDVL_209_2021. Epub ahead ofprint. PMID: 36332088.

70. GuignantM, Tedbirt B, Murrell DF, Amagai M, Aoki V, Bauer J, Ciancinni G, Culton D,Daneshpazhooh M, De D, Fairley J, Hall R, Kim SC, Korman NJ, KowalewskiC, Mimouni D, Patsatsi A, Hebert V, Saleh MAM, Schmidt E, Sprecher E, Uzun S,Venning V, Werth VP, Zillikens D, Joly P. How Do Experts Treat Patients withBullous Pemphigoid around the World? An International Survey. JIDInnov. 2022 Apr 12;2(4):100129. doi: 10.1016/j.xjidi.2022.100129. PMID:35860447; PMCID: PMC9289845.

71. MahajanR, Manjunath S, Madakshira MG, De D, Handa S, Chatterjee D, Radotra BD.Topical Gentamicin 0.1% Promotes Collagen 7 Expression in Recessive DystrophicEpidermolysis Bullosa. Indian Dermatol Online J. 2022 Jun 24;13(4):480-483.doi: 10.4103/idoj.idoj_554_21. PMID: 36262564; PMCID: PMC9574149.

72. MahajanR, Handa S, Kumar S, Chatterji D, Saikia UN, De D. Pediatric autoimmuneblistering disorders - a five-year demographic profile and therapy experience.Int J Dermatol. 2022Dec;61(12):1511-1518.

73. De D, KaushikA, Handa S, Mahajan R, Chatterjee D, Saikia B, Saikia UN, Radotra BD, Minz RW.Bullous pemphigoid in India: Review of cases registered in an autoimmunebullous disease clinic. Indian J Dermatol Venereol Leprol. 2023Jul-Aug;89(4):553-557. doi: 10.25259/IJDVL_1417_20.

74. SinghN, Handa S, Mahajan R, Sachdeva N, De D. Comparison of the efficacy andcost-effectiveness of an immunologically targeted low-dose rituximab protocolwith the conventional rheumatoid arthritis protocol in severe pemphigus. ClinExp Dermatol. 2022 Aug;47(8):1508-1516. doi: 10.1111/ced.15213. Epub 2022 Jun25. PMID: 35384021.

75. JainK, Thakur V, Handa S, Thakur N, Shilpa, Sachdeva N, Mahajan R, De D. Arandomised clinical trial to assess the adjuvant potential of methotrexate tocorticosteroids in mucosal or limited mucocutaneous pemphigus vulgaris. SciRep. 2022 May 9;12(1):7525. doi: 10.1038/s41598-022-11387-2. PMID: 35534494;PMCID: PMC9085868.

76. MahajanR, Daroach M, Handa S, De D. Randomized controlled trial to compare theeffectiveness and safety of low dose dexamethasone oral mini-pulse versusdiphenylcyclopropenone contact sensitisation in severe pediatric alopeciaareata. Dermatol Ther. 2022 Nov;35(11):e15810. doi: 10.1111/dth.15810. Epub2022 Sep 19. PMID: 36086930.

77. Mahajan R, Raj D, De D, Handa S. Cross-sectional study shows an association betweenpaediatric lichen planus and dyslipidemia. Indian J Dermatol. 2022Sep-Oct;67(5):531-534. doi: 10.4103/ijd.ijd_100_22.

78. Mukherjee S, Gunasekaran PK, Saini L, Saini AG, De D, Malhi P. Cutaneous and ocular manifestations in Indian childrenwith neurocutaneous syndromes: A cross-sectional study. Trop Doct. 2022Oct;52(4):572-575. doi: 10.1177/00494755221102012.

79. Saini L, Mukherjee S, Gunasekaran PK, Malhi P, Saini AG, De D,Padhy S, Ahuja C, Suthar R, Sahu JK, Sankhyan N, Yadav J, Sharawat IK. Sleep problems in children with neurocutaneoussyndromes: a cross-sectional study. J Child Neurol. 2022 Oct;37(10-11):864-870. doi:10.1177/08830738221114560.

80. Jindal AK, Handa S, Loganathan SK, Sudhakar M, Kaushik A, Suri D,Pandiarajan V, Rawat A, Gupta A, De D, Mahajan R, Singh S. Juvenile localized scleroderma: A single-centreexperience from India. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):598-604. doi:10.1111/jdv.18765.

81. AntigaE, Bech R, Maglie R, Genovese G, Borradori L, Bockle B, Caproni M, Caux F,Chandran NS, Corrà A, D'Amore F, Daneshpazhooh M, De D, Didona D,Dmochowski M, Drenovska K, Ehrchen J, Feliciani C, Goebeler M, Groves R,Günther C, Handa S, Hofmann SC, Horvath B, Ioannidis D, Jedlickova H,Kowalewski C, Kridin K, Joly P, Lim YL, Marinovic B, Maverakis E, Meijer J,Patsatsi A, Pincelli C, Prost C, Setterfield J, Sprecher E, Skiljevic D, TasanenK, Uzun S, Van Beek N, Vassileva S, Vorobyev A, Vujic I, Wang G, Wang M,Wozniak K, Yayli S, Zambruno G, Hashimoto T, Schmidt E, Mascarò JM Jr, MarzanoAV. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplasticautoimmune multiorgan syndrome initiated by the European Academy of Dermatologyand Venereology (EADV). J Eur Acad Dermatol Venereol. 2023 Jun;37(6):1118-1134.doi: 10.1111/jdv.18931.

82. KaushikH, Mahajan R, Dabas G, Shrivastava N, Ashraf R, De D, Pal A, Kumar R,Handa S. A cross-sectional study to find association of VDR gene polymorphismwith non-syndromic congenital ichthyosis and with vitamin D deficiency. ArchDermatol Res. 2023 Apr;315(3):551-557. doi: 10.1007/s00403-022-02399-z. Epub2022 Oct 3.

83. De D, AshrafR, Mehta H, Handa S, Mahajan R. Outcome of COVID-19 in patients with autoimmunebullous diseases. Indian J Dermatol Venereol Leprol. 2023Nov-Dec;89(6):862-866. doi: 10.25259/IJDVL_551_2022.

84. SoodR, Chatterjee D, De D, Nahar Saikia U, Mahajan R, Handa S, Dass RadotraB. Accuracy of serration pattern analysis by direct immunofluorescence insubepidermal autoimmune blistering diseases. Indian J Dermatol Venereol Leprol.2023 Aug 10:1-6. doi: 10.25259/IJDVL_20_2023.

85. ThakurN, Chatterjee D, Dev A, Shilpa, Mahajan R, Handa S, De D. Utility of C3dand C4d immunohistochemical staining in formalin-fixed skin or mucosal biopsyspecimens in diagnosis of bullous pemphigoid and mucous membrane pemphigoid.Sci Rep. 2023 Jul 12;13(1):11283. doi: 10.1038/s41598-023-38193-8. PMID: 37438374;PMCID: PMC10338454.

86. KambojP, Kaushik A, Handa S, Dutta P, Saikia UN, Pal A, De D. Effects ofmetformin on clinical, hormonal and relevant gene expression parameters inpatients with acne: an observational study. Clin Exp Dermatol. 2023 Jun5;48(6):617-622. doi: 10.1093/ced/llad020.

87. SilA, Das A, Patra AC, Kumar R, Pandhi D, De D, Seetharam K, Bhari N, GuptaN, Rao R, Mittal A, Rathore S, Poojary S, Barua S, Jagadeesan S, Mohanty S,Padhi T, Sankar V, Betkerur J, Das NK. Impact of COVID-19 Pandemic onDermatology Teaching Program in India: A Survey on the Faculty and Residents'Perspective. Indian Dermatol Online J. 2023 Aug 29;14(5):643-652. doi:10.4103/idoj.idoj_85_23.

88. HandaS, Bhattacharjee R, Thakur V, De D, Mahajan R. Contact hypersensitivityto Indian standard patch test series correlates with disease severity amongchildren with atopic dermatitis. Indian J Dermatol Venereol Leprol. 2023 Jul17:1-6. doi: 10.25259/IJDVL_492_2022.

89. De D, ShilpaS, Kumar S, Drenovska K, Mehta H, van Beek N, Sachdeva N, Fleva A, Shahid M,Handa S, Giannakou A, Naumova E, Mahajan R, Kyriakou A, Lesichkova S, LazaridouE, Radotra BD, Kishore K, Schmidt E, Vassileva S, Patsatsi A. Differences amongIndian and European pemphigus patients based on demographics, clinicalparameters and propensity for relapse: results of a prospective bicontinentalcohort study. Eur J Dermatol. 2023 Dec 1;33(6):642-647. doi:10.1684/ejd.2023.4631. PMID: 38465545.

90. De D,Hanumanthu V, Jinagal J, Handa S, Mahajan R, Chatterjee D, Kumar V, Saikia B,Saikia UN, Radotra BD, Minz RW. Clinico-demographic characteristics of mucous membranepemphigoid in India: A retrospective analysis of patients registered with anautoimmune bullous disease clinic. IndianJ Dermatol Venereol Leprol. doi: 10.25259/IJDVL_273_2023

91. KambojP, Khullar G, Handa S, Pal A, Saikia UN, De D. Role of FoxO1 in Acne and Effect ofIsotretinoin on FoxO1 Expression. Indian Dermatol OnlineJ. 2024 Feb 28;15(2):252-254. doi: 10.4103/idoj.idoj_455_23.

92. ReddyP, Mahajan R, Mehta H, De D, Bhatia A, Kumar R, Handa S. Increased prevalence of metabolic syndrome andnon-alcoholic fatty liver disease in children with atopic dermatitis: Acase-control study from northern India.Pediatr Dermatol. 2024 Jan 2. doi:10.1111/pde.15502.

93. Singh S, SharmaA, Malhi K, De D, Handa S, Mahajan R, Gorsi U. Sirolimus in dermatology: Jackof many trades. Indian J Dermatol Venereol Leprol. 2024 Apr 29:1-4. doi:10.25259/IJDVL_869_2023. Epub ahead of print. PMID: 38841953.

94. Jinagal J, GuptaB, Hanumanthu V, Chatterjee D, Limbu S, Malhotra C, Gupta A, Jain AK, YangzesS, Mahajan R, Handa S, Pandav SS, De D. Ocular Cicatricial Pemphigoid inYoung Patients. Cornea. 2024 Aug 1;43(8):1015-1021. doi:10.1097/ICO.0000000000003547. Epub 2024 Apr 26. PMID: 38692674.

95. Prarthana T,Handa S, Goel S, Mahajan R, De D. Construction and validation of anaudio-visual tool to instruct caregivers of patients with pemphigus inphotographing skin and oral cavity lesions during tele-consultation: Across-sectional study. Indian J Dermatol Venereol Leprol. 2024 Apr 16:1-5. doi:10.25259/IJDVL_361_2023. Epub ahead of print. PMID: 38841977.

Exploration of role of BP180 and LAM332 genetic variants and altered protein function in frequent ocular involvement and fibrosis in mucous membrane pemphigoid and not in bullous pemphigoid